Suppr超能文献

常规白细胞分类流式细胞术HematoFlow™方法:一种用于自动验证的新标记系统。

The routine leukocyte differential flow cytometry HematoFlow™ method: A new flagging system for automatic validation.

作者信息

Allou Kaoutar, Vial Jean-Philippe, Béné Marie C, Lacombe Francis

机构信息

University Hospital of Bordeaux, Haut Lévêque Hospital, Pessac, France.

University Hospital of Nantes, France.

出版信息

Cytometry B Clin Cytom. 2015 Nov-Dec;88(6):375-84. doi: 10.1002/cyto.b.21242. Epub 2015 Sep 21.

Abstract

The complete blood cell count and white blood cell differential are the first step in the biological diagnosis of hematological diseases. Both are currently performed by automated instruments which control data and produce alerts. If such flags are activated, the automated differential cannot be validated and the operator must activate a visual blood smear review. Microscopic examination is still today the reference method despite its lack of sensitivity and reproducibility. The HematoFlow™ (Beckman Coulter) system is the first flow cytometry commercialized method designed for the routine differential. Using six markers in five colors and an automated gating strategy, it provides differentials proven to be reliable for 17 leukocyte subpopulations detection. Relying first on a retrospective analysis of 6,462 blood samples processed by HematoFlow™, thresholds were determined to detect the presence of immature granulocytes and/or blast cells. All possible gating strategy misclassifications of leukocyte subpopulations were then summarized in a systematic nomenclature leading to the development of an original flag system based on the detection of aberrant localization of cell events in specific new bivariate histograms. Ultimately, more than 50% of the results could be automatically validated using the HematoFlow™ system, without any false negative, thereby dramatically contributing to an important decrease of technicians' workload. Moreover a noticeable help was given for smear review interpretation and new immunological flags led to the confirmation of blood disease after classical immunophenotyping. These results were confirmed in a second prospective study including 15,335 cases, where more than 50% of the results were automatically validated by this new flag system. MFC stands as being more and more essential for analyzing differentials in routine and this new flag system could greatly improve its implementation.

摘要

全血细胞计数和白细胞分类是血液系统疾病生物学诊断的第一步。目前这两项检查均由控制数据并发出警报的自动化仪器完成。如果此类标记被激活,则自动化分类结果无法得到验证,操作人员必须启动人工血涂片复查。尽管显微镜检查缺乏敏感性和可重复性,但至今仍是参考方法。HematoFlow™(贝克曼库尔特公司)系统是首个商业化的用于常规分类的流式细胞术方法。该系统使用五种颜色的六种标记物以及自动设门策略,能提供经证实对17种白细胞亚群检测可靠的分类结果。首先通过对6462份经HematoFlow™处理的血样进行回顾性分析,确定了检测未成熟粒细胞和/或原始细胞存在的阈值。然后,将白细胞亚群所有可能的设门策略错误分类汇总成一个系统命名法,从而开发出一种基于在特定新双变量直方图中检测细胞事件异常定位的原始标记系统。最终,使用HematoFlow™系统可自动验证超过50%的结果,且无任何假阴性,从而极大地减少了技术人员的工作量。此外,该系统对涂片复查解读有显著帮助,新的免疫标记在经典免疫表型分析后有助于确诊血液疾病。这些结果在第二项纳入15335例病例的前瞻性研究中得到了证实,该新标记系统自动验证了超过50%的结果。在常规分析分类中,流式细胞术越来越重要,而这种新的标记系统可极大地改进其应用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验